GSA Capital Partners LLP Sells 45,531 Shares of Phreesia, Inc. (NYSE:PHR)

Key Points

• GSA Capital Partners LLP reduced its stake in Phreesia, Inc. by 56.4%, resulting in ownership of approximately 0.06% of the company, valued at $900,000.
• Phreesia reported an earnings per share (EPS) of (0.07) for the most recent quarter, beating analysts' expectations of (0.13), while revenue increased by 14.5% year-over-year.
• Analysts maintain a bullish outlook on Phreesia, with a consensus rating of "Buy" and an average price target raised to $32.27.

GSA Capital Partners LLP cut its position in shares of Phreesia, Inc. (NYSE:PHR - Free Report) by 56.4% during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 35,219 shares of the company's stock after selling 45,531 shares during the period. GSA Capital Partners LLP owned 0.06% of Phreesia worth $900,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Principal Financial Group Inc. purchased a new position in shares of Phreesia in the 1st quarter valued at about $1,623,000. Deutsche Bank AG increased its position in shares of Phreesia by 95.9% during the fourth quarter. Deutsche Bank AG now owns 57,297 shares of the company's stock worth $1,442,000 after purchasing an additional 28,047 shares in the last quarter. Bessemer Group Inc. raised its position in shares of Phreesia by 23.2% in the first quarter. Bessemer Group Inc. now owns 47,758 shares of the company's stock valued at $1,222,000 after buying an additional 8,978 shares during the last quarter. SG Americas Securities LLC acquired a new position in Phreesia during the first quarter worth about $462,000. Finally, Raymond James Financial Inc. acquired a new position in Phreesia during the fourth quarter worth about $379,000. Institutional investors and hedge funds own 92.10% of the company's stock.

Phreesia Price Performance

Shares of NYSE:PHR traded up $0.43 during trading on Monday, reaching $26.77. The stock had a trading volume of 115,942 shares, compared to its average volume of 503,017. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.95 and a quick ratio of 1.95. The business's 50-day moving average price is $26.82 and its 200 day moving average price is $26.41. Phreesia, Inc. has a 52 week low of $17.07 and a 52 week high of $30.53. The stock has a market capitalization of $1.59 billion, a PE ratio of -36.17 and a beta of 0.71.

Phreesia (NYSE:PHR - Get Free Report) last announced its earnings results on Wednesday, May 28th. The company reported ($0.07) earnings per share for the quarter, topping analysts' consensus estimates of ($0.13) by $0.06. The firm had revenue of $115.94 million during the quarter, compared to analyst estimates of $115.00 million. Phreesia had a negative net margin of 9.83% and a negative return on equity of 16.23%. The company's revenue for the quarter was up 14.5% compared to the same quarter last year. During the same period in the prior year, the business earned ($0.05) EPS. As a group, equities analysts predict that Phreesia, Inc. will post -1.1 earnings per share for the current year.

Insider Activity at Phreesia

In other news, COO Evan Roberts sold 1,892 shares of the firm's stock in a transaction that occurred on Thursday, July 17th. The shares were sold at an average price of $26.89, for a total transaction of $50,875.88. Following the transaction, the chief operating officer directly owned 772,915 shares of the company's stock, valued at approximately $20,783,684.35. This trade represents a 0.24% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP David Linetsky sold 23,729 shares of the stock in a transaction that occurred on Friday, June 27th. The stock was sold at an average price of $28.50, for a total transaction of $676,276.50. Following the sale, the senior vice president owned 193,510 shares in the company, valued at $5,515,035. This represents a 10.92% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 53,804 shares of company stock valued at $1,510,733. 5.50% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on the company. Truist Financial increased their price target on Phreesia from $34.00 to $35.00 and gave the company a "buy" rating in a report on Thursday, May 29th. Citigroup reaffirmed a "buy" rating on shares of Phreesia in a research report on Wednesday, May 28th. Wall Street Zen upgraded shares of Phreesia from a "hold" rating to a "buy" rating in a research note on Sunday, June 1st. DA Davidson upgraded shares of Phreesia to a "strong-buy" rating in a research report on Tuesday, July 22nd. Finally, KeyCorp raised their target price on Phreesia from $28.00 to $35.00 and gave the company an "overweight" rating in a report on Monday, July 14th. Eleven investment analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Buy" and an average price target of $32.27.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.